Navigation Links
Access to antiretrovirals unlikely to reduce HIV infection rates

A new study by Rebecca Baggaley, Neil Ferguson, and Geoff Garnett (of Imperial College London) suggests that the HIV epidemic in poor countries will not be controlled through antiretroviral drugs alone, even if universal access is achieved. As they demonstrate in an article in the open-access international medical journal PLoS Medicine, without additional prevention methods such as counseling patients and their communities about safe sex, access to drugs is likely to increase HIV/AIDS prevalence.

Sexual transmission of HIV is more likely if the HIV-positive partner has a higher viral load. Because antiretrovirals therapy (ART) slows AIDS progression and reduces viral load in infected individuals, the drugs not only improve the health and prolong the life of those who take them, but also make it less likely that they infect others. As a consequence, ART has been discussed not only as a treatment but also as a prevention tool in its own right.

To test this, Baggaley and colleagues used a model to predict and compare the impacts of alternative strategies of increasing ART access in resource-poor countries. Some of the strategies included the provision of diagnostic laboratories that could routinely measure CD4 counts and viral loads of HIV-infected individuals (only if this is done could people be treated before they develop overt symptoms). They also took into account different ways that people might change their sexual behavior if they get treatment (which might make them feel physically better and more likely to be sexually active) and counseling (which will hopefully increase safe sex practices).

They found that providing ART to all individuals with AIDS symptoms (i.e. those at the late stages of the disease) was likely to increase the prevalence of HIV infection, as these people live longer and become sexually active again. If ART is also provided to HIV-positive individuals at an earlier stage, i.e. when their immune system starts to get
'"/>

Source:Public Library of Science


Page: 1 2

Related biology news :

1. Open Access journals get impressive impact factors
2. Access to existing medical treatments could save more lives than spending to improve the treatments
3. Medical experts: US unlikely to have enough vaccines to stop avian flu
4. Ozone recovering, but unlikely to stabilize at pre-1980 levels, says study
5. Male circumcision reduces risk of HIV transmission from women to men
6. Deficiency of growth hormone and IGF-1 reduces cancer and kidney disease, but creates other problems
7. Use of PET can reduce, may eliminate more strenuous drug development trials with animals
8. Solutions that reduce death of marine life reeled in by International Smart Gear Competition
9. Physiological effects of reduced gravity on bacteria
10. New strategies to reduce hospital-aquired infections
11. New miniaturised chip dramatically reduces time taken for DNA analysis

Post Your Comments:
(Date:11/25/2009)...t professors recently received funding from the Na...ch beneficial to understanding the environment. Th...ckwood, assistant professor in the Department of B...two separate research projects. , His first proj...ies and Functions from the Leaf to the Landscape,"...
(Date:11/24/2009)...s to understanding how sounds associated with Navy... or if they hear it at all. , The same type of ...es to detect flaws in the space shuttle,s behemoth...peek inside the giant head of a whale. The scans a...f a whale,s hearing anatomy using a breakthrough m...
(Date:11/24/2009)...of Medical Toxicology (ACMT) have signed an agreem...nal of Medical Toxicology (JMT), the official jou... previously published by the University of Pennsyl...gy , an international, peer-reviewed journal, is d...medical toxicology. The quarterly journal focuses...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2Rocket science leads to new whale discovery 2Springer and the American College of Medical Toxicology to work together 2Evolutionary forecasting for drug resistance 9991 1Evolutionary forecasting for drug resistance 9991 2Evolutionary forecasting for drug resistance 9991 3Lilly Receives 100 Percent Rating on Corporate Equality Index Survey 57767 1Lilly Receives 100 Percent Rating on Corporate Equality Index Survey 57767 2Equity Capital Management H1N1 Vaccines and Hard to Treat Diseases 28HTDS 29 57763 1Equity Capital Management H1N1 Vaccines and Hard to Treat Diseases 28HTDS 29 57763 2
... the latest American Chemical Society (ACS) News S...-reviewed journals and Chemical & Engineering New...erican Chemical Society as the source for this inf..., Clothing to crow about: Chicken feather suits a...you may snuggle up in warm, cozy sweats made of ch...
...RBOR, Mich. Using new technologies that make it e... the University of Michigan Comprehensive Cancer C...e fused when their chromosomes trade places with e...t to be the driving mechanism that causes certain ... could potentially serve as a marker one day for d...
...VILLE, Fla. Researchers at Mayo Clinic have disco...for late-onset Alzheimer,s disease. , In the Jan...ort the results of their two-stage genome-wide ass...e. The research showed that women who inherited tw...n the X chromosome, are at considerably greater ri...
Other Biology News:American Chemical Society's Weekly PressPac -- Jan. 7, 2009 2American Chemical Society's Weekly PressPac -- Jan. 7, 2009 3American Chemical Society's Weekly PressPac -- Jan. 7, 2009 4American Chemical Society's Weekly PressPac -- Jan. 7, 2009 5American Chemical Society's Weekly PressPac -- Jan. 7, 2009 6American Chemical Society's Weekly PressPac -- Jan. 7, 2009 7American Chemical Society's Weekly PressPac -- Jan. 7, 2009 8American Chemical Society's Weekly PressPac -- Jan. 7, 2009 9U-M researchers discover new genes that fuse in cancer 2Mayo: Variants in gene on X chromosome associated with increased susceptibility to Alzheimer's 2Mayo: Variants in gene on X chromosome associated with increased susceptibility to Alzheimer's 3
(Date:11/24/2009)... Ambassador to also Visit Detroit ,... -- , , ,Who: David Appia, French Ambassador for I...he Invest in France Agency, , , , ,What: Ambassad...s recent pro-business initiatives adopted by Franc...demic landscape for innovation and development., ,...
(Date:11/24/2009)...KJAVIK,Iceland,November24/PRNewswire-FirstCall/--d...atithasreceivednoticefrom,theNasdaqStockMarketthat...ofNovember30,2009andaForm25-NSEwillbefiledwiththe,...ODE,scommonstock,fromlistingonNasdaq,unlessthecomp...anel.Thecompanyhasfiledsuchanappeal,which,willstay...
(Date:11/24/2009)...NGHAI,Nov.24/PRNewswire-Asia/--NODPharmaceuticalsI...asallowedthepatentapplicationfor,itsnano-particleo...ahighlyefficientapproachtoincorporatepeptidesor,pr...liveryofdrugs,otherwiseadministeredasinjections.NO...omanymacromoleculardrugssuchasinsulin,interferon,...
(Date:11/24/2009)... The FBI recently approved the Prome...participating in or generating DNA records for the... Madison, WI USA (PRWEB) -- The FBI recently a...for use by laboratories participating in, or gener...em (NDIS). NDIS currently contains more than seven...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2
..., Ind. - The National Nuclear Security Administrat...t for a research center at Purdue University,s Dis...mmercial and defense applications, Purdue official...ocus on the behavior and reliability of miniature ...nce chosen by the NNSA. , About 35 researchers at...
... , From: Jai P. Nagarkatti, President and CEO Si...E: OXB) and Open,Biosystems, Inc., a privately hel...al settlement of their patent litigation. Sigma-Al...awsuit brought against Open,Biosystems. Open Biosy...awsuit. As part of the settlement Open Biosystems ...
... Halozyme Therapeutics,Inc. (Nasdaq: HALO ), a b...izing products based on the extracellular matrix, ...ults for the three and twelve months,ended Decembe...3, 2008., Jonathan Lim, MD, President and Chief E...t and Chief Scientific Officer, Robert Little, Vic...
Other Biology Technology:Purdue leads center to simulate behavior of micro-electromechanical systems 2Purdue leads center to simulate behavior of micro-electromechanical systems 3Purdue leads center to simulate behavior of micro-electromechanical systems 4Sigma-Aldrich, Oxford BioMedica and Open Biosystems Settle Patent Dispute Over Use of LentiVector Technology in Research Reagents 2Sigma-Aldrich, Oxford BioMedica and Open Biosystems Settle Patent Dispute Over Use of LentiVector Technology in Research Reagents 3Halozyme Therapeutics to Hold Pipeline Update Conference Call on March 14 2
...costatin M (OSM) is a pleiotropic cytokine produce...coma cells. OSM inhibits the growth of some tumour...th muscle and Kaposis sarcoma cell proliferation, ...nsity lipoprotein receptor expression on hepatoma ...
...(R)-17-phenyl trinor Prostaglandin F2α isop...sopropyl ester) is the latanoprost-related isomer ...rted (β) hydroxyl group at C-15. Similar to...03b1; isopropyl ester is a potential impurity in m...
Phenol Red, Free Acid from USB Corp.
...use Anti Nop1p/Fibrillarin (monoclonal) Nop1p/Fi... protein of bakers yeast, Saccharomyces cerevisiae...l for yeast viability and is localized in the nucl...(accession P22087) a component of the nucleolar sm...
Biology Products: